Broaden your "Lens". If all you know is what you know, that is all that you will know. Important insight from @HeartBobH - the Lens representative (applied for and funded position) - They would not have known about candidates without this extra perspective.
How do we pro-actively address racism in training?
Not just reduce the interactions (e.g. have trainee leave)., intercede, build up the education/knowledge, place on team of trainee. Make it clear, racism is NOT acceptable.
#ACC21 - @NMHheartdoc provided a talk at #NCToday that resonates. #Implicitbias is something we all carry about many many things.
We. ALL. Have. Implicit Biases.
1) Recognize it exists 2) Identify what ours are - sociocultural etc. 3) Mitgate, mitigate, mitigate
Thank you to the entire session team. I have been well-taught. Now, to get out and continue to be active!
• • •
Missing some Tweet in this thread? You can try to
force a refresh
💊nutraceuticals ubiquitous and “assumed” by many pts to be heart healthy.
💊💰💸industry
💊 SPORT ➡️ compared to rosuva and placebo, do they impact biomarkers? jacc.org/doi/abs/10.101… @kewatson@ErinMichos@ljlaffin 1/
N=199, randomized single blind
💊 lipid, hsCRP, CMP. Baseline and at 28 days.
💊 1° risk, age 40-75, LDL-C 70-189, borderline to upper intermediate risk (5-20%, estimated 10 yr event)
💊 1° endpt: %LDL-C change vs rosuva
💊2° endpt: biomarkers vs rosuva; vs placebo #aha22 2/
💊 most were at least 7.5% 10 year risk
💊 nice representation of 💃🏽
💊 LDL-C >100 (~125); hsCRP <2.0
🐟interesting drop out rate/protocol deviation, covid era?
🐟LDL-C baseline, similar to reduce it
🐟EPA median 46 ug/mL, higher than reduce it (26), lower than Jelis (96).
🐟hsCRP ~0.40 2/ #aha22
Throwing dollars at “health”doesn’t = improved health. This is staggering. We need to change what and how we deliver #Healthcare and where the $$ are spent #aha22